ACRO BIOMEDICAL CO., LTD. Cash And Cash Equivalents At Carrying Value

• ACRO BIOMEDICAL CO., LTD. showed an increase of +1,889.4% in Cash And Cash Equivalents At Carrying Value from 2019 to 2020.
• This data is from ACRO BIOMEDICAL CO., LTD.'s annual report (Form 10-K), filed with the SEC on April 2, 2021.
• XBRL data for this metric is available from 2014 to 2020 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2015: $31.0 thousand | Q2 2015: $28.8 thousand | Q3 2015: $27.3 thousand | Q4 2015: $15.9 thousand | Q1 2016: $7.7 thousand | Q2 2016: $2.1 thousand | Q4 2016: $2.4 thousand | Q4 2017: $8.5 thousand | Q1 2018: $471.8 thousand | Q2 2018: $4.6 thousand | Q1 2019: $412.00 | Q2 2019: $231.00 | Q4 2019: $911.00 | Q1 2020: $10.6 thousand | Q2 2020: $381.00 | Q3 2020: $156.00 | Q4 2020: $18.1 thousand | Q1 2021: $24.4 thousand | Q2 2021: $215.5 thousand.
• Over the full 9 years of available data (2014 to 2020), ACRO BIOMEDICAL CO., LTD.'s Cash And Cash Equivalents At Carrying Value has grown by 361.7%.
• Historical annual values: Fiscal year 2020: $18.1 thousand | Fiscal year 2019: $911.00 | Fiscal year 2019: $1.5 thousand | Fiscal year 2018: $37.6 thousand | Fiscal year 2018: $1.1 thousand | Fiscal year 2017: $36.8 thousand | Fiscal year 2016: $2.5 thousand | Fiscal year 2015: $27.3 thousand | Fiscal year 2014: $3.9 thousand.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026